Acquired thrombotic thrombocytopenic purpura in a 16-year-old patient: use of proteasome inhibitor for refractory disease control. RBPS [Internet]. 2024 Dec. 31 [cited 2026 Aug. 10];26(1):e51121. Available from: https://periodicos.ufes.br/rbps/article/view/51121